Tieu Lena, Uchi Jasmine, Patel Nirva, Meghani Mihir, Patel Padmaja, Nguyen Yen
Gilead, Foster City, CA, USA (LT); VeganMed, Vacaville, CA, USA (JU, YN); Harvard Law School, Cambridge, MA, USA (NP); Hindu American Foundation, Washington, DC, USA (MM); and American College of Lifestyle Medicine, Chesterfield, MO, USA (PP).
Am J Lifestyle Med. 2022 Oct 30;18(3):351-363. doi: 10.1177/15598276221135538. eCollection 2024 May-Jun.
Many patients seek medications without animal-derived ingredients for a multitude of reasons. The purpose of this comprehensive qualitative review is to assess current literature on the topic of animal-free medications and identify the roles that key stakeholders can play in addressing the needs of these patients. A comprehensive literature search was conducted on PubMed and Google Scholar from inception to June 2022 to identify key articles surrounding the topic of animal-free ingredients and medications. The need for animal-free medications impacts not just vegans and vegetarians, but also those with dietary restrictions due to other beliefs. Three key stakeholder initiatives can address the needs of these patients: 1) Healthcare professionals (HCPs) should strive to select appropriate medications considering their patients' religious and/or cultural background; 2) patients must be involved and notify their providers about their dietary requirements; 3) pharmaceutical industry and manufacturers need to consider animal-free product formulations and provide clear labeling. There is a rising interest in animal-free medications and several organizations and advocacy groups have raised concerns for easier access to these medications. However, more regulatory guidance or oversight is needed. For the nearly 25% animal-free medications available in the market, independent certification marks would facilitate informed consumer decision-making.
许多患者出于多种原因寻求不含动物成分的药物。这篇全面的定性综述的目的是评估当前关于无动物药物主题的文献,并确定关键利益相关者在满足这些患者需求方面可以发挥的作用。从创刊到2022年6月,我们在PubMed和谷歌学术上进行了全面的文献检索,以确定围绕无动物成分和药物主题的关键文章。对无动物药物的需求不仅影响纯素食者和素食者,也影响那些因其他信仰而有饮食限制的人。三项关键的利益相关者举措可以满足这些患者的需求:1)医疗保健专业人员(HCPs)应根据患者的宗教和/或文化背景,努力选择合适的药物;2)患者必须参与进来,并告知其医疗服务提供者他们的饮食要求;3)制药行业和制造商需要考虑无动物产品配方,并提供清晰的标签。人们对无动物药物的兴趣日益浓厚,一些组织和倡导团体对更方便获取这些药物表示关切。然而,还需要更多的监管指导或监督。对于市场上近25%的无动物药物,独立认证标志将有助于消费者做出明智的决策。